Changes in corneal morphology associated with chronic epithelial injury

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 1, 1999, Pages 35-42

  Kim, Woo Jung ^a   Helena, Marco C ^c   Mohan, Rahul R ^b   Wilson, Steven E ^b  

^a Sungkyunkwan University   (South Korea)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Box 356485 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA INJURY; CORNEA THICKNESS; EPITHELIUM CELL; KERATOCONUS; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RABBIT; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; APOPTOSIS; CHRONIC DISEASE; CORNEAL DISEASES; CORNEAL STROMA; DEBRIDEMENT; DNA; EPITHELIUM, CORNEAL; EYE INJURIES; HYPERPLASIA; IN SITU NICK-END LABELING; MALE; RABBITS; WOUNDS, NONPENETRATING;

EID: 0032907904     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Wilson SE, He Y-G, Weng J, Li Q, Vital M, Chwang EL. Epithelial injury induces keratocyte apoptosis: hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization. Exp Eye Res. 1996;62:325-338.
2. Wilson SE, Pedroza L, Beuerman R, Hill J. Herpes simplex virus type-1 infection of corneal epithelial cells induces apoptosis of the underlying keratocytes. Exp Eye Res. 1997;64:775-779.
3. Helena MC, Baerveldt F, Kim W-J, Wilson SE. Keratocyte apoptosis following corneal surgery. Invest Ophthalmol Vis Sci. 1998;39: 276-283.
4. Wilson SE. Programmed cell death, wound healing, and laser refractive surgical procedures: molecular-cell biology for the corneal surgeon. J Refract Surg. 1997;13:171-175.
5. Wilson SE, Kim W-J. Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci. 1998;39:220-226.
6. Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiological study of keratoconus. Am J Ophthalmol. 1986;101: 267-273.
7. Coyle JT. Keratoconus and eye rubbing. Am J Ophthalmol. 1984; 97:527-528.
8. Koreman NM. A clinical study of contact-lens-related keratoconus. Am J Ophthalmol. 1986;101:390-396.
9. Macsai MS, Varley GA, Krachmer JH. Development of keratoconus after contact lens wear: patient characteristics. Arch Ophthalmol. 1990;108:534-538
10. Harrison RJ, Klouda PT, Easty DL, Manku M, Charles J, Stewart CM. Association between keratoconus and atopy. Br J Ophthalmol. 1989;73:816-822.
11. Rahi A, Davies P, Ruben M, Lobascher D, Menon J. Keratoconus and coexisting atopic disease. Br J Ophthalmol. 1977;61:761-764.
12. Gold R, Schmied M, Giegerich G, et al. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest. 1994;71:219-225.
13. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:495-501.
14. Mori C, Nakamura N, Okamoto Y, Osawa M, Shiota K. Cytochemical identification of programmed cell death in the fusing fetal mouse palate by specific labelling of DNA fragmentation. Anat Embryol. 1994;190:21-28.
15. Michel-Salmin LA, Tosi-Couture E, Gautier A, McDowall AW, Dubochet J. Electron microscopy of the chromosomes of Dinoflagellate Porocentrum micans: confirmation of Bouligandíss liquid crystal hypothesis. J Ultrastruct Molec Struct Res. 1986;97: 10-30.
16. Wilson SE, Li Q, Weng J, et al. The Fas/Fas Ligand System and Other Modulators of Apoptosis in the Cornea. Invest Ophthalmol Vis Sci. 1996;37:1582-1592.
17. Mohan RR, Liang Q, Kim W-J, Helena MC, Baerveldt F, Wilson SE. Apoptosis in the cornea: further characterization of Fas/Fas ligand system. Exp Eye Res. 1997;65:575-589.
18. Drubaix I, Legeais JM, Robert L, Renard G. Corneal hyaluronan content during post-ablation healing: evidence for a transient depth-dependent contralateral effect. Exp Eye Res. 1997;64:301-304.
19. Hanna KD, Pouliquen YM, Waring GO 3rd, Savoldelli M, Fantes F, Thompson KP. Corneal wound healing in monkeys after repeated excimer laser photorefractive keratectomy. Arch Ophthalmol. 1992;110:1286-1291.
20. Del Pero RA, Gigstad JE, Roberts AD. A refractive and histopathologic study of excimer laser keratectomy in primates. Am J Ophthalmol. 1990;109:419-429.
21. Wilson SE, Walker JW, Chwang EL, He Y-G. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), their receptors, FGF receptor-2, and the cells of the cornea. Invest Ophthalmol Vis Sci. 1993;34:2544-2561.
22. Li Q, Weng J, Mohan R, et al. Hepatocyte growth factor (HGF) and HGF receptor protein in lacrimal gland, tears, and cornea. Invest Ophthalmol Vis Sci. 1996;37:727-739.
23. Wilson SE, He Y-G, Weng J, Zeiske JD, Jester JV, Schultz GS. Effect of epidermal growth factor, hepatocyte growth factor, and keratinocyte growth factor, on proliferation, motility, and differentiation of human corneal epithelial cells. Exp Eye Res. 1994;59:665-678.
24. Tervo T, Vesaluoma M, Bennett GL, et al. Tear hepatocyte growth factor (HGF) availability increases markedly after excimer laser surface ablation. Exp Eye Res. 1997;64:501-504.
25. Khaw PT, Schultz GS, MacKay SL, et al. Detection of transforming growth factor-alpha messenger RNA and protein in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 1992;33:3302-3306.
26. Fabre EJ, Bureau J, Pouliquen Y, Lorans G. Binding sites for human interleukin-1 alpha, gamma interferon and tumor necrosis factor on cultured fibroblasts of normal cornea and keratoconus. Curr Eye Res. 1991;10:585-592.
27. Bereau J, Fabre EJ, Hecquet C, Pouliquen Y, Lorans G. Modification of prostaglandin E2 and collagen synthesis in keratoconus fibroblasts associated with an increase of interleukin-1 alpha receptor number. Can Roy Acad Sci III. 1993;316:425-430.
28. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251-306.
29. Arends MJ, Wyllie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol. 1991;32:223-254.
30. Robert L, Schillinger G, Moczar M, Jungua S, Moczar B. Biochemical study of keratoconus. Arch Ophthalmol (Paris). 1970;30:590-608.
31. Tsubota K, Mashima Y, Murata H, Sato N, Ogata T. Corneal epithelium in keratoconus. Cornea. 1995;14:77-83.
32. Sawaguchi S, Yue BYJT, Sugar J, Gilboy JE. Lysosomal enzyme abnormalities in keratoconus. Arch Ophthalmol. 1989;107:1507-1510.
33. Fukuchi T, Yue BYJT, Sugar J, Lam S. Lysosomal enzyme activities in conjunctival tissues of patients with keratoconus. Arch Ophthalmol. 1994;112:1368-1374.
34. Kao WWY, Vergnes JP, Ebert J, SundarRaj CV, Brown SI. Increased collagenase and gelatinase activities in keratoconus. Biochem Biophys Res Commun. 1982;107:929-936.
35. Rehany U, Lahav M, Shoshan S. Collagenolytic activity in keratoconus. Ann Ophthalmol. 1982;14:751-754.
36. Ihalainen A, Sato T, Forsius H, Peltonen L. Increased in type I and type IV collagenolytic activity in primary cultures of keratoconus cornea. Eur J Clin Invest. 1986;16:78-84.
37. Critchfield JW, Calandra AJ, Nesburn AB, Kenney MC. Keratoconus I: biochemical studies of normal keratoconus corneas. Exp Eye Res. 1988;46:953-963.
38. Kenney MC, Chwa M, Escobar M. Brown D. Altered gelatinolytic activity by keratoconus corneal cells. Biochem Biophys Res Commun. 1989;161:353-357.
39. Sawaguchi S, Twining SS, Yue BYJT, Wilson PM, Sugar J, Chan SK. α1-Proteinase inhibitor levels in keratoconus. Exp Eye Res. 1990; 50:549-554.
40. Sawaguchi S, Twining SS, Yue BYJT, et al. α2-Macroglobulin levels in normal human and keratoconus corneas. Invest Ophthalmol Vis Sci. 1994;35:4008-4014.
41. Fini ME, Yue BYJT, Sugar J. Collagenolytic/gelatinolytic metalloproteinases in normal and keratoconus corneas. Exp Eye Res. 1992;11:849-862
42. Brown D, Chwa MM, Opbroek A, Kenney MC. Keratoconus corneas: increased gelatinolytic activity appears after modification of inhibitors. Curr Eye Res. 1993;12:571-581.